Search details
1.
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Ann Intern Med
; 177(6): 711-718, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38768457
2.
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Ann Intern Med
; 177(4): 449-457, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38560901
3.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
Rheumatology (Oxford)
; 63(3): 751-764, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-37314967
4.
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden.
Haematologica
; 2024 Jan 11.
Article
in English
| MEDLINE | ID: mdl-38205512
5.
Trends of perceived disruption in healthcare services during the pandemic: findings from the COVID-19 National Resilience Cohort in Iceland.
Eur J Public Health
; 34(2): 394-401, 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38129962
6.
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.
Ann Rheum Dis
; 82(6): 820-828, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36813538
7.
Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen.
Rheumatology (Oxford)
; 62(2): 886-893, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-35460235
8.
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study.
Haematologica
; 108(12): 3392-3398, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37439374
9.
Validity of chronic disease diagnoses in Icelandic healthcare registries.
Scand J Public Health
; 51(2): 173-178, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-34903105
10.
The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-being.
J Intern Med
; 291(6): 837-848, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35112416
11.
Does biologic therapy impact the development of PsA among patients with psoriasis?
Ann Rheum Dis
; 81(1): 80-86, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34615637
12.
Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study.
Rheumatology (Oxford)
; 61(5): 1877-1884, 2022 05 05.
Article
in English
| MEDLINE | ID: mdl-34508558
13.
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration.
Ann Rheum Dis
; 80(11): 1410-1418, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34083206
14.
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study.
Rheumatology (Oxford)
; 60(8): 3656-3668, 2021 08 02.
Article
in English
| MEDLINE | ID: mdl-33401297
15.
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.
Rheumatology (Oxford)
; 60(8): 3635-3645, 2021 08 02.
Article
in English
| MEDLINE | ID: mdl-33367900
16.
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.
Eur J Haematol
; 106(3): 380-388, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33295006
17.
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
Rheumatology (Oxford)
; 59(9): 2455-2461, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-31960053
18.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Rheumatology (Oxford)
; 59(7): 1640-1650, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-31665497
19.
Comment on: Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen: reply.
Rheumatology (Oxford)
; 62(4): e134-e135, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36161472
20.
Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic review.
Rheumatol Int
; 38(8): 1385-1397, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29124396